Skin cancer is one of the most common cancers worldwide and is growing in incidence due to rising sun exposure, lifestyle changes, and environmental factors. The good news? It is also one of the most treatable forms of cancer, especially when diagnosed early. India is a preferred destination for affordable and high-quality skin cancer care, attracting patients from around the globe.
The average cost of skin cancer treatment in India ranges from ₹80,000 to ₹3,50,000 ($950 to $4,200), depending on the type of skin cancer, the stage of disease, and the treatment approach chosen—be it surgery, radiation, immunotherapy, or targeted therapy. Advanced cases requiring multiple therapies may cost between ₹5,00,000 to ₹12,00,000 ($6,000 to $14,500) over the entire course of treatment.
Despite being significantly more affordable, Indian hospitals deliver world-class care using international protocols, FDA-approved drugs, and board-certified oncologists. On average, patients save 60–80% compared to treatment costs in the US, UK, and Australia.
Skin cancer is a disease in which skin cells grow uncontrollably in an abnormal manner. It usually starts in the outermost layer of the skin (epidermis) and is most often caused by excessive exposure to ultraviolet (UV) rays from the sun or tanning beds. While some skin cancers grow slowly and rarely spread, others can become aggressive and life-threatening if not treated early.
There are three main types of skin cancer, each with its own behavior and treatment plan.
Other rare forms include Merkel cell carcinoma, Kaposi sarcoma, and cutaneous T-cell lymphoma, which require specialized treatment approaches.
Yes, most skin cancers are highly curable when detected early and treated correctly. Treatments in India range from minor outpatient surgeries to advanced therapies like immunotherapy, chemotherapy, or radiation for more complex cases.
Anyone diagnosed with skin cancer (whether it's a small basal cell carcinoma or an aggressive melanoma) needs timely treatment to prevent further growth, tissue damage, or spread to other parts of the body. Skin cancer treatment is tailored based on the type, location, and stage of cancer, as well as the patient's overall health.
Identifying the early symptoms of skin cancer is key to successful treatment. Skin cancer often begins as visible changes on the skin's surface, so paying attention to new spots, growths, or changes in moles is crucial.
While the exact symptoms vary by type, the most common warning signs are:
Any unusual change in your skin (especially one that persists or grows) should be evaluated. Early-stage skin cancers are highly treatable, and timely action often prevents the need for complex or expensive treatments.
India offers a comprehensive range of treatments for skin cancer, from basic surgical removal to advanced therapies like immunotherapy and targeted drugs. The exact treatment plan depends on the type of skin cancer, its stage, location, and whether it has spread.
India has become a top destination for affordable, high-quality cancer care. The cost of skin cancer treatment in India depends on factors like the type of cancer (BCC, SCC, melanoma), treatment method, hospital location, and whether multiple treatments are combined.
On average, skin cancer treatment in India costs between ₹80,000 and ₹3,50,000 ($950 – $4,200) for early-stage cases and ₹5,00,000 to ₹12,00,000 ($6,000 – $14,500) for advanced-stage or metastatic cancer requiring immunotherapy or targeted therapy.
Treatment Type |
Estimated Cost (INR) |
Estimated Cost (USD) |
Consultation & Diagnosis |
₹2,000 – ₹10,000 |
$25 – $120 |
Biopsy & Histopathology |
₹5,000 – ₹12,000 |
$60 – $145 |
Molecular Testing (e.g., BRAF) |
₹15,000 – ₹45,000 |
$180 – $540 |
Surgical Excision |
₹40,000 – ₹1,00,000 |
$500 – $1,200 |
Mohs Micrographic Surgery |
₹1,00,000 – ₹1,80,000 |
$1,200 – $2,200 |
Cryotherapy |
₹10,000 – ₹30,000 |
$120 – $360 |
Radiation Therapy (Full Cycle) |
₹1,50,000 – ₹3,00,000 |
$1,800 – $3,600 |
Chemotherapy (Multiple Cycles) |
₹80,000 – ₹2,00,000 |
$950 – $2,400 |
Immunotherapy (Per Dose) |
₹2,00,000 – ₹4,00,000 |
$2,400 – $4,800 |
Targeted Therapy (Per Cycle) |
₹1,00,000 – ₹3,50,000 |
$1,200 – $4,200 |
Note: Prices may vary based on the city, hospital reputation, drug brand (branded vs biosimilar), and complexity of the case.
One of the biggest reasons overseas patients choose India for skin cancer treatment is the significant cost advantage. Without compromising on quality, Indian hospitals offer therapy at 60–80% lower prices than those in developed countries like the United States, the UK, or Australia.
Country |
Basic Treatment Cost (Early Stage) |
Advanced Treatment Cost (With Immunotherapy/Targeted Therapy) |
Includes Surgery, Diagnostics & Drugs |
Waiting Time |
India |
$950 – $4,200 |
$6,000 – $14,500 |
Yes |
Minimal (2–5 days) |
United States |
$15,000 – $35,000 |
$60,000 – $100,000+ |
Often excludes full drug cost |
Weeks to months |
United Kingdom |
$12,000 – $25,000 (Private) |
$50,000+ (Private) |
Limited by NHS availability |
Long (3–6 months) |
Australia |
$10,000 – $20,000 |
$40,000 – $80,000 |
Partial coverage with Medicare |
Moderate to long |
Thailand |
$7,000 – $12,000 |
$18,000 – $40,000 |
Yes |
Short |
Turkey |
$6,000 – $10,000 |
$15,000 – $30,000 |
Yes |
Short |
The total cost of treating skin cancer in India can vary from patient to patient. While India offers highly affordable care compared to many Western countries, several factors determine how much a patient will ultimately spend.
India has become a trusted destination for patients seeking high-quality, affordable cancer care, including those dealing with skin cancer. But it's not just the cost that makes India attractive. Patients from over 100 countries travel here for personalized treatment, world-class infrastructure, and compassionate care that rivals the best healthcare systems in the world.
Globally Trained Oncologists and Surgeons: India's top hospitals are staffed with oncologists, dermatologists, and surgical specialists who have trained at renowned institutions in the USA, UK, Germany, and Singapore. Their experience with advanced techniques like Mohs surgery, skin grafting, immunotherapy, and targeted therapy ensures high-quality outcomes.
Comprehensive Cancer Centers Under One Roof: From diagnosis and staging to surgery, radiotherapy, and follow-up care, Indian hospitals offer everything within the same facility. It streamlines the entire patient journey and eliminates the delays and confusion that often occur in multi-center treatment systems abroad.
Affordable Access to the Latest Therapies: India offers FDA-approved targeted drugs and immunotherapies, often at a fraction of the global cost, thanks to its strong generic drug manufacturing base. Advanced treatments like nivolumab, pembrolizumab, and BRAF inhibitors are readily available without long waiting lists.
Fast Treatment with No Waiting Time: Unlike public systems in other countries, where patients wait weeks or months for diagnostic scans or surgery slots, Indian hospitals can begin treatment within days of diagnosis. It is crucial for aggressive cancers like melanoma.
Personalized Care Plans: Every patient's skin cancer journey is unique. Indian hospitals conduct detailed evaluations, including pathology reviews and genetic testing, before proposing a customized treatment plan. It is something that's often missing in standardized public systems abroad.
India's success rate in treating skin cancer has steadily improved, thanks to early diagnosis, access to cutting-edge therapies, and the growing expertise of its oncology specialists. Whether it's a minor basal cell carcinoma or an aggressive case of melanoma, Indian hospitals follow globally accepted treatment protocols to ensure the best possible outcomes.
For early-detected skin cancers such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), the cure rate in India is above 90–95% with surgical excision or cryotherapy. Mohs surgery, when available, further improves outcomes by preserving healthy tissue while eradicating the cancer.
In cases of advanced melanoma, success is now measured by progression-free survival and quality of life. With access to BRAF inhibitors, PD-1 immunotherapy (like nivolumab or pembrolizumab), and expert oncology care, patients in India have experienced significant tumor shrinkage and survival extensions, often comparable to outcomes in the US and Europe.
Indian hospitals emphasize not only survival but also skin preservation, cosmetic results, and emotional well-being. With reconstructive surgery, scar minimization, and psychological support, patients return to daily life faster and with confidence.
Patients from across the world have shared life-changing experiences after receiving skin cancer treatment in India. One name that frequently stands out is Dr. Ankur Bahl, a renowned medical oncologist at Fortis Memorial Research Institute (FMRI), Gurgaon. Known for his expertise in targeted therapies and compassionate care, Dr. Bahl has helped many international patients win their battle against skin cancer.
"After I was diagnosed with advanced-stage melanoma, the doctors in my country gave me very few options. A friend recommended Dr. Ankur Bahl in India. He immediately conducted genetic testing and started me on targeted therapy. Within weeks, my symptoms began to improve. I've been under his care for over a year now, and my scans show no new spread. I feel healthier and more hopeful than ever."
— Aysha R., Muscat, Oman
"I had a recurring sore on my scalp that wouldn't heal. After a biopsy in Nairobi confirmed it was skin cancer, I flew to India to see Dr. Bahl. He coordinated my surgery and post-operative radiation within 10 days. Everything was handled professionally—from airport pickup to accommodation. I'm now cancer-free and back home with my family."
— George M., Nairobi, Kenya
"I was very nervous about having surgery on my face. Dr. Ankur Bahl and his team explained the procedure clearly and arranged Mohs surgery with a plastic surgeon. Not only was the cancer removed, but my scar is barely visible. I couldn't have asked for better care."
— Heena A., Dubai, UAE
The primary cause of skin cancer is continuous exposure to UV radiation. Other risk factors include fair skin, weakened immunity, family history, and having many moles or unusual skin lesions.
Warning signs include new moles, sores that won't heal, scaly patches, changing moles, or spots that bleed or itch. A dermatologist or oncologist should examine any suspicious changes on your skin.
Yes. Early-stage skin cancers are highly curable with treatments like surgical excision or cryotherapy. Even in advanced stages, therapies such as immunotherapy or targeted drugs can offer long-term control.
Melanoma is considered the most dangerous form because it spreads faster than other types. However, early detection and modern treatments have improved survival outcomes significantly.
Yes, recurrence is possible, especially if the original cancer was not entirely removed or if you have ongoing risk factors. Regular checkups and follow-ups are essential.
Immunotherapy helps the body's immune system recognize and attack cancer cells. It is especially effective in advanced melanoma and can improve quality of living.
For early-stage cancers, treatment costs between ₹80,000 to ₹3,50,000 ($950 – $4,200). Advanced treatments requiring immunotherapy or targeted therapy may cost ₹5,00,000 to ₹12,00,000 ($6,000 – $14,500) or more.
Yes. Patients save 60–80% compared to the US, UK, or Australia. Despite the lower cost, India offers high-quality care, global-standard drugs, and internationally trained oncologists.
Most hospitals provide transparent, all-inclusive packages for international patients. However, extras like visa fees, post-discharge accommodation, or follow-up scans may be billed separately.
Yes. Drugs like nivolumab, pembrolizumab, and BRAF inhibitors are available. Indian pharmacies also offer approved biosimilars at lower prices, reducing costs without sacrificing quality.